Literature DB >> 10450388

Ocular surface disease in intensive care unit patients.

F Mercieca1, P Suresh, A Morton, A Tullo.   

Abstract

PURPOSE: To assess the prevalence and natural history of ocular surface disease in patients in an intensive care unit (ICU) and to identify any predisposing factors in order to improve eye care management protocols.
METHODS: The eyes of all patients admitted to an ICU between February and May 1998 were examined at least weekly. The eyelid position, presence of conjunctival oedema, degree of keratopathy and sedation score were documented at every assessment.
RESULTS: Twenty-six patients in an ICU were followed throughout their stay, which ranged from 3 days to 10 weeks. Eleven patients (42%) had some degree of keratopathy, which was detected in the majority in the first week of their stay. The presence of ocular surface disease was closely correlated with the degree of lagophthalmos, which in turn is closely related to the depth of sedation or paralysis.
CONCLUSIONS: In this first ever longitudinal study it was found that assessment of lid position in ICU patients is the single most important observation to be carried out. A management algorithm derived from this evidence is based on daily observation and selective lid taping and shows encouraging early results.

Entities:  

Mesh:

Year:  1999        PMID: 10450388     DOI: 10.1038/eye.1999.57

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  14 in total

1.  Assessment of corneal epitheliopathy in the critically ill.

Authors:  Daniel G Ezra; Marie Healy; Andrew Coombes
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

2.  Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes.

Authors:  D G Ezra; G Lewis; M Healy; A Coombes
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

3.  Eye care in the intensive care unit.

Authors:  Benjamin J Hearne; Elewys G Hearne; Hugh Montgomery; Susan L Lightman
Journal:  J Intensive Care Soc       Date:  2018-03-22

4.  Prevention of exposure keratopathy in intensive care unit.

Authors:  Hua Shan; Du Min
Journal:  Int J Ophthalmol       Date:  2010-12-18       Impact factor: 1.779

5.  Randomised trial comparing ocular lubricants and polyacrylamide hydrogel dressings in the prevention of exposure keratopathy in the critically ill.

Authors:  Daniel G Ezra; Michelle P Y Chan; Lola Solebo; Aeesha P Malik; Elizabeth Crane; Andrew Coombes; Marie Healy
Journal:  Intensive Care Med       Date:  2008-09-23       Impact factor: 17.440

6.  A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient.

Authors:  Natasha Koroloff; Robert Boots; Jeff Lipman; Peter Thomas; Claire Rickard; Fiona Coyer
Journal:  Intensive Care Med       Date:  2004-03-10       Impact factor: 17.440

7.  Efficacy of Simple Eye Ointment, Polyethylene Cover, and Eyelid Taping in Prevention of Ocular Surface Disorders in Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Mehdi Ahmadinejad; Esmat Karbasi; Yunes Jahani; Maryam Ahmadipour; Maryam Soltaninejad; Zahra Karzari
Journal:  Crit Care Res Pract       Date:  2020-04-09

8.  Ocular surface disorders in intensive care unit patients.

Authors:  Tuba Berra Saritas; Banu Bozkurt; Baris Simsek; Zeynep Cakmak; Mehmet Ozdemir; Alper Yosunkaya
Journal:  ScientificWorldJournal       Date:  2013-10-29

9.  Prediction of risk and incidence of dry eye in critical patients.

Authors:  Diego Dias de Araújo; Natália Gherardi Almeida; Priscila Marinho Aleixo Silva; Nayara Souza Ribeiro; Andreza Werli-Alvarenga; Tânia Couto Machado Chianca
Journal:  Rev Lat Am Enfermagem       Date:  2016-05-17

10.  Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults: a two-phase prospective cohort study.

Authors:  Obaid Kousha; Zubaid Kousha; Jonathan Paddle
Journal:  Crit Care       Date:  2018-01-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.